Merbecoviruses, closely related to the Middle East respiratory syndrome coronavirus, circulate in hedgehogs throughout Europe and Asia, raising concerns about zoonotic transmission to humans and domestic animals. However, it is not clear how these viruses enter host cells. Here we tested three coronavirus receptors from European hedgehogs (Erinaceus europaeus) in cell-based assays and identified aminopeptidase N (APN) as a receptor for hedgehog merbecoviruses. We verified it by pseudotype experiments using an in vitro reporter system based on replication competent vesicular stomatitis virus and protein binding assays. Hedgehog coronavirus spike proteins showed enhanced infectivity when produced at 33 °C, approximating the physiological hedgehog body temperature, as compared with 37 °C. A screen of 30 mammalian APN orthologues showed restricted cross-species receptor use, including the inability to use human APN. Electron cryomicroscopy revealed a distinct glycoprotein-receptor interface unlike known coronavirus spike-APN interactions, clarifying species barriers. These findings broaden our understanding of receptor use across merbecoviruses and betacoronaviruses and inform risk assessments for viral emergence.
M. Jin, Victoria A. Jefferson, Zhe Zhao et al.· Nature Microbiology· 0 citations
Flaviviruses are enveloped, positive-strand RNA viruses that cause millions of infections in the human population annually. Although Zika virus (ZIKV) had been detected in humans as early as the 1950s, its reemergence in South America in 2015 resulted in a global health crisis. While flaviviruses encode 10 proteins that can be post-translationally modified by host enzymes, little is known regarding post-translational modifications (PTMs) of the flavivirus proteome. We used mass spectrometry to comprehensively identify host-driven PTMs on the ZIKV proteome. This approach allowed us to identify 43 PTMs across 8 ZIKV proteins, including several that are highly conserved within the Flavivirus genus. Notably, we found two phosphosites on the ZIKV envelope protein that are functionally important for viral propagation. Both appear to regulate viral particle release, while one also impacts ZIKV cytopathogenicity. Additionally, we discovered host kinases that interact with ZIKV proteins and determined that Bosutinib—an FDA-approved tyrosine kinase inhibitor that targets some of these host kinases—impairs ZIKV growth, in part by blocking phosphorylation of a tyrosine residue on the envelope protein. Thus, we have defined a high-resolution map of host-driven PTMs on ZIKV proteins as well as cellular interacting kinases, uncovered novel mechanisms of host driven-regulation of ZIKV particle release and cytopathogenicity, and identified an FDA-approved inhibitor of ZIKV growth.
Inessa Manuelyan, Anna M. Schmoker, B. Yount et al.· PLoS Pathogens· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
